Human Cannabinoid Pharmacokinetics

Cited by (1,000)

Items 501–600 of 1,000

1. Cannabis, possible cardiac deaths and the coroner in Ireland
   William Patrick Tormey · 2012 · Irish Journal of Medical Science (1971 -)
2. Chlorination Kinetics of 11-Nor-9-carboxy-Δ9-tetrahydrocannabinol: Effects of pH and Humic Acid
   Allison L. Mackie, Yuri Park, Graham A. Gagnon · 2017 · Environmental Science & Technology
3. Aversiveness and Meaningfulness of Uncomfortable Experiences with Edible Cannabis
   Stacey L. Farmer, Melissa N. Slavin, Mallory Loflin, Rachel R. Luba, Mitch Earleywine · 2019 · Journal of Psychoactive Drugs
4. Association between cannabis use and complications related to ulcerative colitis in hospitalized patients
   Chimezie U. Mbachi, Bashar M. Attar, Olamide Oyenubi, Yuchen Wang, Efesomwan Aisien, Isaac Paintsil, Madhu Mathew, Oyintayo Ajiboye, Carlos Roberto Simons-Linares, William E. Trick et al. · 2019 · Medicine
5. 11-OH-THC in hair as marker of active cannabis consumption: Estimating a reliable cut-off by evaluation of 672 THC-positive hair samples
   Sara Casati, Ilaria Angeli, Alessandro Ravelli, Massimo DEL FABBRO, Mauro Minoli, Marica Orioli · 2019 · Forensic Science International
6. Cannabis use in pregnancy and breastfeeding: The pharmacist’s role
   Erin Davis, Tiffany A Lee, John T. Weber, Shawn Bugden · 2020 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
7. Patterns and correlates of workplace and non-workplace cannabis use among Canadian workers before the legalization of non-medical cannabis
   Nancy Carnide, Hyunmi Lee, Michael R. Frone, Andrea D Furlan, Peter M. Smith · 2020 · Drug and Alcohol Dependence
8. Differential Cognitive Performance in Females and Males with Regular Cannabis Use
   Ashley M. Schnakenberg Martin, Deepak Cyril D’Souza, Sharlene D. Newman, William P. Hetrick, Brian F. O’Donnell · 2021 · Journal of the International Neuropsychological Society
9. Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities
   Ashley L. Merianos, Alex M. Russell, E. Melinda Mahabee‐Gittens, Adam E. Barry, Meng Yang, Hsien‐Chang Lin · 2021 · Addictive Behaviors
10. A broader view on deriving a reference dose for THC traces in foods
    Bernhard Beitzke, David W. Pate · 2021 · Critical Reviews in Toxicology
11. Development of a rapid column-switching LC-MS/MS method for the quantification of THCCOOH and THCCOOH-glucuronide in whole blood for assessing cannabis consumption frequency
    Marianne Hädener, Wolfgang Weinmann, Stefan Schürch, Stefan König · 2016 · Analytical and Bioanalytical Chemistry
12. Spontaneous, anecdotal, retrospective, open-label study on the efficacy, safety and tolerability of cannabis galenical preparation (Bedrocan)
    Beniamino Palmieri, Carmen Laurino, Maria Vadalà · 2019 · International Journal of Pharmacy Practice
13. After the Grand Opening: Assessing Cannabis Supply and Demand in Washington State
    Beau Kilmer, Steven Davenport, Rosanna Smart, Jonathan P. Caulkins, Greg Midgette · 2019 · RAND Corporation eBooks
14. Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants
    Erica N. Peters, Irina Mosesova, Laura MacNair, Ryan G. Vandrey, M. Hunter Land, Mark A. Ware, Cynthia L. Turcotte, Marcel O. Bonn‐Miller · 2021 · Journal of Analytical Toxicology
15. THC (Δ9‐Tetrahydrocannabinol) Exerts Neuroprotective Effect in Glutamate‐affected Murine Primary Mesencephalic Cultures Through Restoring Mitochondrial Membrane Potential and Anti‐apoptosis Involving CB1Receptor‐dependent Mechanism
    Chi Huu Nguyen, Christopher Krewenka, Khaled Radad, Barbara Kranner, Alexandra Huber, Johanna Catharina Duvigneau, Ingrid Miller, Rudolf Moldzio · 2016 · Phytotherapy Research
16. Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow‐up study
    Michael Krämer, Martin Schäper, Kristina Dücker, Alexandra Philipsen, Moritz Losacker, Nadine Dreimüller, Jan Engelmann, Burkhard Madea, Cornelius Heß · 2021 · Drug Testing and Analysis
17. Short communication: Tissue distribution of major cannabinoids following intraperitoneal injection in male rats
    Cody A. C. Lust, Xinjie Lois Lin, Erin M. Rock, Cheryl L. Limebeer, Linda A. Parker, David W.L. · 2022 · PLoS ONE
18. Medicinal cannabis pharmacokinetics and potential methods of delivery
    Lidya Kebede, Seyedehsara Masoomi Dezfooli, Ali Seyfoddin · 2022 · Pharmaceutical Development and Technology
19. Impacto de la legalización del consumo recreativo del cannabis
    Manuel Isorna Folgar, Francisco Pascual, Ester Aso, F. Árias · 2022 · Adicciones
20. A Review on the Bioactivity of Cannabinoids on Zebrafish Models: Emphasis on Neurodevelopment
    Rosario Licitra, Maria Marchese, Valentina Naef, Asahi Ogi, Marco Martinelli, Claudia Kiferle, Baldassare Fronte, Filippo Maria Santorelli · 2022 · Biomedicines
21. Determining impacts of prenatal cannabis exposure on cannabis vapor self-administration using a novel response-contingent vapor model in pregnant rat dams
    Halle V. Weimar, Alexandra N. Malena, Darren E. Ginder, Amanda M Brown, Nicholas C. Glodosky, Samantha L. Baglot, Matthew N. Hill, Ryan J. McLaughlin · 2023 · Addiction Neuroscience
22. Pharmacokinetics of delta-9-tetrahydrocannabinol following acute cannabis smoke exposure in mice; effects of sex, age, and strain
    Emely A. Gazarov, Sabrina Zequeira, Alexandria S. Senetra, John Clair Howard, Abhisheak Sharma, Christopher R. McCurdy, Jada M. Lewis, Jennifer L. Bizon, Barry Setlow · 2023 · Frontiers in Pharmacology
23. A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance
    Thomas R. Arkell, Brooke Manning, Luke A. Downey, Amie C. Hayley · 2023 · CNS Drugs
24. Spray freeze dried cannabidiol with dipalmitoylphosphatidylcholine (DPPC) for inhalation and solubility enhancement
    Waiting Tai, Jonathon Carl Arnold, Hak‐Kim Chan, Philip Chi Lip Kwok · 2024 · International Journal of Pharmaceutics
25. Significant enhancement of 11‐Hydroxy‐THC detection by formation of picolinic acid esters and application of liquid chromatography/multi stage mass spectrometry (LC‐MS3): Application to hair and oral fluid analysis
    Detlef Thieme, Ulf Sachs, Hans Sachs, Christine Mary Moore · 2014 · Drug Testing and Analysis
26. Placenta as alternative specimen to detect in utero cannabis exposure: A systematic review of the literature
    Daniela Marchetti, Gerardo Di Masi, Francesca Cittadini, Giuseppe La Monaca, Nadia De Giovanni · 2017 · Reproductive Toxicology
27. Δ9-Tetrahydrocannabinol induces endocannabinoid accumulation in mouse hepatocytes: antagonism by Fabp1 gene ablation
    Avery L. McIntosh, Gregory G. Martin, Huan Huang, Danilo Landrock, Ann B. Kier, Friedhelm Schroeder · 2018 · Journal of Lipid Research
28. Preliminary Evidence for Cannabis and Nicotine Urinary Metabolites as Predictors of Verbal Memory Performance and Learning Among Young Adults
    Natasha E. Wade, Rachel E. Baca, Kelly Elizabeth Courtney, Connor J. McCabe, Maria Alejandra Infante, Marilyn Ann Huestis, Joanna Jacobus · 2021 · Journal of the International Neuropsychological Society
29. Cannabis, cannabidiol and tetrahydrocannabinol in sport: an overview
    Michael Kennedy · 2022 · Internal Medicine Journal
30. A Retrospective Cohort Study That Examined the Impact of Cannabis Consumption on Long-Term Kidney Outcomes
    Joshua L. Rein, Hui Zeng, Georgia Brown Faulkner, Kinsuk Chauhan, Edward D. Siew, Mark M. Wurfel, Amit X. Garg, Thida C. Tan, James S. Kaufman, Vernon M. Chinchilli et al. · 2023 · Cannabis and Cannabinoid Research
31. Irinotecan and Δ9-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers
    Ana Lucić Vrdoljak, Nino Fuchs, Anja Mikolić, Suzana Žunec, Irena Brčić Karačonji, Andreja Jurič, Ljerka Prester, Vedran Micek, Marijana Neuberg, Samir Čanović et al. · 2018 · Molecules
32. Model‐based analysis on systemic availability of co‐administered cannabinoids after controlled vaporised administration
    Zheng Liu, Peter Galettis, Samantha J. Broyd, Hendrika van Hell, Lisa‐Marie Greenwood, Peter de Krey, Amy Steigler, Xiao Zhu, Jennifer Schneider, Nadia Solowij et al. · 2019 · Internal Medicine Journal
33. A patient-centric liquid chromatography-tandem mass spectrometry microsampling assay for analysis of cannabinoids in human whole blood: Application to pediatric pharmacokinetic study
    Ganesh S. Moorthy, Christina Vedar, Mary Ann DiLiberto, Athena F. Zuppa · 2019 · Journal of Chromatography B
34. Cannabinoids as an alternative option for conventional analgesics in cancer pain management: A pharmacogenomics perspective
    Mahadev Rao, Anmi Jose, Levin Thomas, Gayathri Baburaj, Murali Munisamy · 2020 · Indian Journal of Palliative Care
35. Surgery-Related Considerations in Treating People Who Use Cannabis
    Mark M. Mims, Aniruddha C. Parikh, Zainab Sandhu, Noah DeMoss, Rachad I. Mhawej, Lurdes Queimado · 2024 · JAMA Otolaryngology–Head & Neck Surgery
36. Standardized Cannabis Smoke Extract Induces Inflammation in Human Lung Fibroblasts
    Noof Aloufi, Yoon Namkung, Hussein Traboulsi, Emily T. Wilson, Stéphane A. Laporte, Barbara L.F. Kaplan, Matthew K. Ross, Parameswaran Nair, David H. Eidelman, Carolyn J. Baglole · 2022 · Frontiers in Pharmacology
37. Simultaneous quantification of urinary tobacco and marijuana metabolites using solid-supported liquid-liquid extraction coupled with liquid chromatography tandem mass spectrometry
    Volha Yakimavets, Tian Qiu, Parinya Panuwet, Priya E D'Souza, Patricia A. Brennan, Anne Lang Dunlop, Peter Barry Ryan, Dana Boyd Barr · 2022 · Journal of Chromatography B
38. Crystallization behavior of milk fat, palm oil, palm kernel oil, and cocoa butter with and without the addition of cannabidiol
    Joseph Cooney, Isaac Hilton, Melissa Abigail Marsh, Annalisa Jones, Silvana Martini · 2022 · Journal of the American Oil Chemists Society
39. “Breaking bud”: the effect of direct chemical modifications of phytocannabinoids on their bioavailability, physiological effects, and therapeutic potential
    Abhinandan Banerjee, John J. Hayward, John Frederick Trant · 2023 · Organic & Biomolecular Chemistry
40. The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer’s Disease
    Václav Trojan, Leoš Landa, Alexandra Šulcová, Jiří Slíva, Radovan Hřib · 2023 · Biomolecules
41. Assessing Cannabis Use in People with Psychosis
    Edward Chesney, Will Lawn, Philip K. McGuire · 2023 · Cannabis and Cannabinoid Research
42. Enhancing transmucosal delivery of CBD through nanoemulsion: in vitro and in vivo studies
    Romina Provenzano, Carmen De Caro, Antonella Vitiello, Luana Izzo, Alberto Ritieni, Francesca Ungaro, Fabiana Quaglia, Emilio Russo, Agnese Miro, Ivana d’Angelo · 2023 · Drug Delivery and Translational Research
43. Does medicinal cannabis affect depression, anxiety, and stress in people with cancer? A systematic review and meta-analysis of intervention studies
    Megan Crichton, Thusharika Dilrukshi Dissanayaka, Wolfgang Marx, Elizabeth Gamage, Nikolaj Travica, Alison Pauline Bowers, Elisabeth A. Isenring, Patsy M. Yates, Skye Marshall · 2024 · Maturitas
44. Cannabinoid-Induced Inhibition of Morphine Glucuronidation and the Potential for In Vivo Drug–Drug Interactions
    Shelby Coates, Keti Bardhi, Philip J. Lazarus · 2024 · Pharmaceutics
45. Interactive effects of alcohol and cannabis quantities in the prediction of same‐day negative consequences among young adults
    Jeffrey D. Wardell, Sophie G. Coelho, Kyra N. Farrelly, Nicolle Fox, John Alastair Cunningham, Roisin M. O’Connor, Christian S. Hendershot · 2024 · Alcoholism Clinical and Experimental Research
46. A critical review of the occurrence, detection, and treatment of Δ9-tetrahydrocannabinol in aquatic environments
    Yuri Park, Allison L. Mackie, Graham A. Gagnon · 2016 · Environmental Reviews
47. Medicinal Cannabis: Issues of evidence
    Kylie O’Brien · 2019 · European Journal of Integrative Medicine
48. Suspected Acute Respiratory Distress Syndrome Associated With the Use of Intravenous Lipid Emulsion Therapy in a Dog: A Case Report
    Heike Botha, Samuel H. Jennings, Saya A. Press, Stephanie A. Istvan · 2019 · Frontiers in Veterinary Science
49. Yield of new hemp varieties for medical purposes under semi-arid Mediterranean environment conditions
    Iván Francisco García-Tejero, Almudena Hernández, Carlos Ferreiro‐Vera, Vı́ctor Hugo Durán Zuazo, Jesus Hidalgo García, Carolina Sánchez-Carnerero Callado, Salvatore Casano · 2020 · Comunicata Scientiae
50. Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study
    Carlo Baraldi, Flavia Lo Castro, Andrea Negro, Anna Ferrari, Maria Michela Cainazzo, Luca Pani, Simona Guérzoni · 2021 · Pain Medicine
51. Cannabinoids in rheumatology: Friend, foe or a bystander?
    Nibha Jain, Arumugam Moorthy · 2022 · Musculoskeletal Care
52. Stability and test–retest reliability of neuronavigated TMS measures of corticospinal and intracortical excitability
    Jean-Marc Therrien-Blanchet, Marie Chantal Ferland, Marie-Andrée Rousseau, Meriem Badri, Emelie Boucher, Amira Merabtine, Lydia Helena Hofmann, Hugo Théoret · 2022 · Brain Research
53. Oral inhalation of cannabidiol delivered from a metered dose inhaler to alleviate cytokine production induced by SARS-CoV-2 and pollutants
    Teerapol Srichana, Charisopon Chunhachaichana, Roongnapa Suedee, Somchai Sawatdee, Narumon Changsan · 2022 · Journal of Drug Delivery Science and Technology
54. Disentangling Medicinal and Recreational cannabis Use Among People Living with HIV: An Ecological Momentary Assessment Study
    Jeffrey D. Wardell, Sergio Rueda, Nicolle Fox, Cecilia Theresa Costiniuk, Mohammad-Ali Jenabian, Shari L. Margolese, Enrico Mandarino, Paul A. Shuper, Christian S. Hendershot, John Alastair Cunningham et al. · 2022 · AIDS and Behavior
55. Can toxicokinetics of (synthetic) cannabinoids in pigs after pulmonary administration be upscaled to humans by allometric techniques?
    Nadine Schaefer, Jan‐Georg Wojtyniak, Ann-Katrin Kröll, Christina Koerbel, Matthias W. Laschke, Thorsten Lehr, Michael Dieter Menger, Hans H. Maurer, Markus Robert Meyer, Peter Harald Schmidt · 2018 · Biochemical Pharmacology
56. Effects of Δ9-tetrahydrocannabinol on irinotecan-induced clinical effects in rats
    Ljerka Prester, Anja Mikolić, Andreja Jurič, Nino Fuchs, Marijana Neuberg, Ana Lucić Vrdoljak, Irena Brčić Karačonji · 2018 · Chemico-Biological Interactions
57. The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice
    Kristen R. Trexler, S. Olivia Vanegas, Justin L. Poklis, Steven G. Kinsey · 2020 · Drug and Alcohol Dependence
58. Cannabinoids, Inner Ear, Hearing, and Tinnitus: A Neuroimmunological Perspective
    Paola Perin, Alex Mabou Tagne, Paolo Enrico, Franca Marino, Marco Cosentino, Roberto Pizzala, Cinzia Boselli · 2020 · Frontiers in Neurology
59. Disparities in use modalities among adults who currently use cannabis, 2022–2023
    Meman Diaby, Osayande Agbonlahor, Bethany Shorey Fennell, Joy L. Hart, Delvon T. Mattingly · 2025 · Journal of Cannabis Research
60. Marijuana and Opioid Use during Pregnancy: Using Zebrafish to Gain Understanding of Congenital Anomalies Caused by Drug Exposure during Development
    Swapnalee Sarmah, Marília Ribeiro Sales Cadena, Pabyton Gonçalves Cadena, James A. Marrs · 2020 · Biomedicines
61. Recent advances in drug delivery to the central nervous system by inhalation
    Waiting Tai, Philip Chi Lip Kwok · 2022 · Expert Opinion on Drug Delivery
62. ‘A glimmer of hope’: perceptions, barriers, and drivers for medicinal cannabis use amongst Australian and New Zealand people with endometriosis – a qualitative study
    Justin Sinclair, Jason Anthony Abbott, Antonina A Mikocka‐Walus, Cecilia Hoi Man Ng, Jerome J. Sarris, Subhadra Evans, Mike Armour · 2023 · Reproduction and Fertility
63. Factors influencing the in situ formation of Δ9‐THC from cannabidiol during GC–MS analysis
    Ya‐Chih Cheng, Sarah Kerrigan · 2023 · Drug Testing and Analysis
64. Sex differences in the acute effects of oral THC: a randomized, placebo-controlled, crossover human laboratory study
    Ardavan Mohammad Aghaei, Lia Urban Spillane, Brian P. Pittman, L. Taylor Flynn, João Paulo De Aquino, Anahita Bassir Nia, Mohini Ranganathan · 2024 · Psychopharmacology
65. Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality
    Antonio J. Carrascosa, Francisco Navarrete, Raquel Saldaña, María S. García‐Gutiérrez, Belinda Montalbán Moreno, Daniela Navarro, Fernando M. Gómez-Guijarro, Ani Gasparyan, Elena Murcia-Sánchez, Abraham B. Torregrosa et al. · 2024 · International Journal of Molecular Sciences
66. International perspectives on physician knowledge, attitudes, and practices related to medical cannabis
    Shariful A. Syed, Jatinder Singh, Hussien Ahmed Elkholy, Irena Rojnić Palavra, Marko Tomičević, Anamarija Petek Eric, Mariana Pinto da Costa, Sinan Gülöksüz, Rajiv Radhakrishnan · 2025 · Frontiers in Public Health
67. Acute cannabis intoxication among the paediatric population
    Ginevra Malta, Giuseppe Davide Albano, Gianluca Lavanco, Anna Brancato, Carla Cannizzaro, Antonina Argo, Simona Contorno, Fulvio Plescia, Stefania Zerbo · 2025 · Frontiers in Toxicology
68. Synthesis of stable cannabidiol (CBD) nanoparticles in suspension
    Roman Štukelj, Metka Benčina, Mattia Fanetti, Matjaž Valant, M. Drab, Aleš Iglič, Veronika Kralj‐Iglič · 2019 · Materiali in tehnologije
69. Medical Cannabis for Headache Pain: a Primer for Clinicians
    Robert Duarte, Stephen Dahmer, Shayna Y. Sanguinetti, Grace Forde, Diana P. Duarte, Lawrence F. Kobak · 2021 · Current Pain and Headache Reports
70. A Clinical Framework for Assessing Cannabis-Related Impairment Risk
    Caroline A. MacCallum, Lindsay A. Lo, Carly A. Pistawka, April L. Christiansen, Michael R. Boivin, Melissa Snider-Adler · 2022 · Frontiers in Psychiatry
71. Cannabis and Pediatric Inflammatory Bowel Disease
    Edward J. Hoffenberg, Heike Newman, Colm B. Collins, Sally E. Tarbell, Kristina L. Leinwand · 2016 · Journal of Pediatric Gastroenterology and Nutrition
72. A fast and reliable method for quantitation of THC and its 2 main metabolites in whole blood by GC–MS/MS (TQD)
    André L. Castro, Sónia Tarelho, Paula Melo, João Miguel Franco · 2018 · Forensic Science International
73. Structural and Functional Interaction of Δ9-Tetrahydrocannabinol with Liver Fatty Acid Binding Protein (FABP1)
    Huan Huang, Avery L. McIntosh, Gregory G. Martin, Lawrence J. Dangott, Ann B. Kier, Friedhelm Schroeder · 2018 · Biochemistry
74. Mental Health and Medical Cannabis Use among Youth and Young Adults in Canada
    Elle Wadsworth, Cesar Leos‐Toro, David G. Hammond · 2019 · Substance Use & Misuse
75. Disposable 3D Printed Electrode for the Electrochemical Detection of Delta-9-Tetrahydrocannabinol in Aqueous Solution and 11-Nor-9-Carboxy-Tetrahydrocannabinol in Saliva
    Érica Naomi Oiye, Maria Fernanda Muzetti Ribeiro, Bruno Ferreira, Rodrigo de Castro Baker Botelho, Marcelo Firmino de Oliveira · 2020 · Brazilian Journal of Forensic Science Medical Law and Bioethics
76. Unresolved Discrepancies between Cannabinoid Test Results for Infant Urine
    Vilte Barakauskas, Rebecka Davis, Matthew D. Krasowski, Gwendolyn A. McMillin · 2012 · Clinical Chemistry
77. Marijuana in the Workplace
    Jennan Atkins Phillips, MICHAEL G. HOLLAND, Debra D. Baldwin, Linda Gifford Meuleveld, Kathryn L. Mueller, Brett Perkison, Mark J. Upfal, Marianne Dreger · 2015 · Journal of Occupational and Environmental Medicine
78. Cannabinoid Mixture Affects the Fate and Functions of B Cells through the Modulation of the Caspase and MAP Kinase Pathways
    Marie-Claude Lampron, Isabelle Paré, Mohammed Mousa Al-Zharani, Abdelhabib Semlali, Lionel Loubaki · 2023 · Cells
79. Disposition of a single oral dose of a cannabidiol medication in healthy cats
    Tom Jukier, Crisanta Cruz‐Espindola, Douglas R. Martin, Dawn Merton Boothe · 2023 · Frontiers in Veterinary Science
80. Daily associations with cannabis use and sleep quality in anxious cannabis users
    L. Cinnamon Bidwell, SR Sznitman, Renée Martin‐Willett, LH Hitchcock · 2023 · Behavioral Sleep Medicine
81. Self-report methodology for quantifying standardized cannabis consumption in milligrams delta-9-tetrahydrocannabinol
    Sarah F. Larsen, Allegra J. Johnson, Mary E. Larimer, Stephen R. Dager, Natalia M. Kleinhans · 2023 · The American Journal of Drug and Alcohol Abuse
82. Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases
    Dinesh Thapa, Leon N. Warne, Marco Falasca · 2023 · International Journal of Molecular Sciences
83. Thoughtfully Integrating Cannabis Products Into Chronic Pain Treatment
    Kevin F. Boehnke, Christopher L. Wu, Daniel Joseph Clauw · 2023 · Anesthesia & Analgesia
84. Clinical examination findings and electrolyte abnormalities of dogs with marijuana/tetrahydrocannabinol toxicity: 223 cases (January 2017–July 2021)
    Erin M. Binagia, Elizabeth A. Gregory, Igor Yankin · 2024 · Journal of the American Veterinary Medical Association
85. Structure elucidation of the designer drug N‐(1‐amino‐3,3‐dimethyl‐1‐oxobutan‐2‐yl)‐1‐(5‐fluoropentyl)‐3‐(4‐fluorophenyl)‐pyrazole‐5‐carboxamide and the relevance of predicted 13C NMR shifts – a case study
    Ulrich Girreser, Peter Rösner, А. Н. Васильев · 2015 · Drug Testing and Analysis
86. Marijuana—Perinatal and Legal Issues With Use During Pregnancy
    Cynthia F. Krening, Keri Hanson · 2018 · The Journal of Perinatal & Neonatal Nursing
87. Partitioning of phytocannabinoids between faeces and water – Implications for wastewater-based epidemiology
    Aaron J. Pandopulos, Bradley S. Simpson, Jason M. White, Richard Bade, Cobus Gerber · 2021 · The Science of The Total Environment
88. A Survey of Topical Cannabis Use in Canada
    Farhan Mahmood, Megan M. Lim, Mark G. Kirchhof · 2021 · Journal of Cutaneous Medicine and Surgery
89. Effects of 28 days of cannabis abstinence on cognition in major depressive disorder: A pilot study
    Maryam Sorkhou, Rachel Allison Rabin, Jennifer S. Rabin, Stefan M. Kloiber, Roger S. McIntyre, Tony Peter George · 2022 · American Journal on Addictions
90. Will tetrahydrocannabinol be formed from cannabidiol in gastric fluid? An in vivo experiment
    Simon Franz, Josefine Herzog, Gisela Skopp, Frank Mußhoff · 2022 · International Journal of Legal Medicine
91. Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey
    Anastasia S. Suraev, Llewellyn Mills, Sarah V. Abelev, Thomas R. Arkell, Nicholas Lintzeris, Iain S. McGregor · 2023 · Nature and Science of Sleep
92. Vaporized Delta-9-tetrahydrocannabinol Inhalation in Female Sprague Dawley Rats: A Pharmacokinetic and Behavioral Assessment
    Samantha L. Penman, Erin C. Berthold, Abrianna Mihalkovic, Nikki Hammond, Christopher R. McCurdy, Kenneth Blum, Rina D. Eiden, Abhisheak Sharma, Panayotis K. Thanos · 2023 · Current Pharmaceutical Design
93. FABP5 is important for cognitive function and is an important regulator of the physiological effects and pharmacokinetics of acute Δ9 tetrahydrocannabinol inhalation in mice
    Samantha L. Penman, Nicole M. Roeder, Erin C. Berthold, Alexandria S. Senetra, Matthew Marion, Brittany Richardson, Olivia White, Nathan L. Fearby, Christopher R. McCurdy, John Hamilton et al. · 2023 · Pharmacology Biochemistry and Behavior
94. Integrating environmental and self-report data to refine cannabis prevalence estimates in a major urban area of Switzerland
    Frederic M. Béen, Christian Schneider, Frank Zobel, Olivier Delémont, Pierre Esseiva · 2016 · International Journal of Drug Policy
95. Oximes short-acting CB1 receptor agonists
    Michael S. Malamas, Jimit Girish Raghav, Xiaoyu Ma, Chandrashekhar Honrao, JodiAnne T. Wood, Othman Benchama, Han Zhou, Srikrishnan Mallipeddi, Alexandros Makriyannis · 2018 · Bioorganic & Medicinal Chemistry
96. S-adenosyl-l-methionine (SAMe), cannabidiol (CBD), and kratom in psychiatric disorders: Clinical and mechanistic considerations
    Michael Levine, Jin Gao, Senthil Kumaran Satyanarayanan, Sarah Berman, Jack T. Rogers, David Mischoulon · 2019 · Brain Behavior and Immunity
97. Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers
    Timothy A. Couttas, Carola Boost, Franziska Pahlisch, Eliska B. Sykorova, Juliane K. Mueller, Beverly Jieu, Judith E. Leweke, Inga Dammann, Anna Hoffmann, Martin Löffler et al. · 2024 · BMJ Mental Health
98. Quality and safety of hemp meal as a protein supplement for nonlactating dairy cows
    F. Addo, Kim Ominski, Chengbo Yang, J. C. B. Plaizier · 2023 · Journal of Dairy Science
99. Effects of Cannabidiol in Inflammation: A Review of Pre-clinical and Clinical Findings
    Michaela Sklenárová, Martin Šíma, Ondřej Slanař · 2023 · Prague Medical Report
100. Development, Characterization and Pharmacological Evaluation of Cannabidiol-Loaded Long Circulating Niosomes
     Viliana Gugleva, Katerina Ahchiyska, Dilyana Georgieva, Rositsa Mihaylova, Spiro Konstantinov, Erik Dimitrov, Natalia Toncheva-Moncheva, Stanislav Rangelov, Aleksander Foryś, Barbara Trzebicka et al. · 2023 · Pharmaceutics